Aeva (AEVA) Q4 2025 earnings review
Aeva Secures Major Production Win as Revenue Doubles, but a Long Path to SOP Remains
Aeva delivered a milestone quarter, officially converting its joint development agreement into a series production contract with a Top European passenger OEM. Revenue doubled YoY to $18.1M in FY25, and Q4 gross margins flipped firmly positive. The company continues to validate its 4D LiDAR technology with a new Top 5 OEM development program and Nvidia platform integration. However, with the major production Start of Production (SOP) targeted for 2028, Aeva must carefully manage its $122M cash pile and $125M facility to bridge the multi-year gap to high-volume automotive revenue.
๐ Bull Case
Converting the top European OEM to an exclusive Tier-1 production contract (SOP 2028) transforms Aeva from a theoretical tech platform into a booked automotive supplier, forcing competitors to play catch-up.
Nvidia's platform integration, the Forterra defense win, and the new Omni sensor prove the technology can penetrate shorter-cycle markets, which is crucial for near-term cash generation.
๐ป Bear Case
With major automotive volumes not arriving until 2027-2028, Aeva must survive a long 'valley of death.' Generating $18M in revenue while burning $115M in operating cash leaves zero room for execution errors.
Despite shrinking operating losses, cash burn worsened YoY. Accounts receivable and inventory spiked, tying up precious capital and exposing potential scaling friction.
โ๏ธ Verdict: โช
Neutral. The technological validation is immense, and the revenue trajectory is accelerating. However, the sheer duration until major automotive series production (2028) against a $115M annual cash burn makes this a story of financial endurance. Shorter-cycle industrial and defense execution is mandatory to prevent future dilution.
Key Themes
European OEM Win Validates Technology
After quarters of 'late-stage negotiations', Aeva officially landed the major production contract as the exclusive Tier-1 LiDAR supplier for a top European passenger OEM's global L3 program (excluding China). This validates the 4D LiDAR technology over legacy time-of-flight solutions. With a targeted SOP in 2028, this sets a reference design that is already attracting fast followers, evidenced by a new joint development program with a Top 5 passenger OEM.
Short-Cycle Markets Muting the Auto Delay
Passenger car programs take years to materialize into revenue. To survive until 2028, Aeva is smartly pivoting toward defense and industrial AI. The company secured its first defense win with Forterra for autonomous ground vehicles and launched 'Omni', a compact sensor designed for robotics. These segments have shorter sales cycles and will be critical to hitting the ambitious FY26 revenue targets.
Nvidia Reference Selection Lowers Friction
Nvidia integrated Aeva's 4D LiDAR as the reference sensor for its DRIVE Hyperion platform. Because DRIVE Hyperion is the foundational architecture used by leading automakers to build autonomous features, this deep software integration drastically lowers the R&D barrier for new customers to adopt Aeva's hardware. It is a massive technological endorsement.
The 'Valley of Death' to 2028
The timeline to the European OEM's SOP is 2028. Daimler Truck's rollout is 2027. Aeva burned $115M in operating cash in FY25. With $121.9M in cash and marketable securities plus a $125M debt facility, the company has roughly two years of runway. Unless industrial and defense revenues scale explosively, Aeva is staring down the barrel of an equity raise before the high-volume auto revenue arrives.
Working Capital Drain Contradicts Cost Narrative
Management touted a narrowing operating loss as proof of scaling efficiency, but the cash flow statement tells a different story. Operating cash burn actually worsened to $115M (from $106.9M in FY24). The culprit? A massive drag from working capital. Accounts receivable nearly tripled to $3.4M, and inventory spiked 146% to $5.8M. Tying up cash in unsold goods and uncollected bills is a dangerous game for an early-stage manufacturer.
Top 5 OEM Deal is Only a Test Run
The announcement of a 'joint development program' with a new Top 5 passenger OEM is a good headline, but it guarantees zero production volume. The automotive industry is littered with development deals that never transition into series production. Investors should treat this as a pipeline metric, not a booked backlog, until a formal Tier-1 contract is signed.
Operating Leverage Emerging as R&D Peaks
Aeva is demonstrating that its core technology development phase is largely over. Research and Development expenses decelerated significantly, falling 17% YoY to $85.4M in FY25. Because the foundational silicon and software are built, the company can double revenue while actually shrinking its cost base, which narrowed the Q4 Non-GAAP operating loss to $23.8M.
Other KPIs
Reversing from deeply negative territory. Despite a disastrous -49% margin in Q2, Q4 gross profit printed a positive $1.3M on $5.6M of sales. Achieving positive unit economics at this early scale proves the manufacturing strategy is viable and provides a foundation for profitable growth.
A slight improvement from FY24's -$152.3M. More importantly, the Non-GAAP Net Loss dropped by $15.6M YoY. The gap between GAAP and Non-GAAP is primarily stock-based compensation ($21.8M) and non-cash warrant liability changes, underscoring that actual operating fundamentals are tightening.
Stable. Comprised of $121.9M in cash, equivalents, and marketable securities, plus a $125M available facility. While this provides a decent buffer, the $115M annual operating cash burn rate means execution on scaling near-term revenue is critical to avoid dilution.
Guidance
Accelerating in absolute dollars, though decelerating slightly in percentage terms (82% implied YoY growth at the midpoint vs 99% in FY25). This target relies heavily on the aggressive ramp of new industrial, defense, and physical AI products, as major automotive volumes are still years away.
Key Questions
Capital Runway to SOP
Given the 2028 SOP for the major European OEM and the $115M annual cash burn, at what point does management anticipate needing additional equity capital, assuming full utilization of the $125M facility?
Working Capital Normalization
Working capital absorbed significant cash in FY25 as inventory and receivables outpaced revenue growth. What are the normalized working capital expectations as you scale toward $36M in FY26?
Gross Margin Sustainability
Can you unpack the 23.5% gross margin achieved in Q4? How much of that was non-recurring engineering (NRE) vs pure product margin, and is this level sustainable into FY26?
